The report mentioned that deletion of the 5′ exons of COL4A6 is not needed to develop diffuse leiomyomatosis in patients with Alport syndrome, contrary to the recognised gene deletion characteristics of patients with AS-DL. The gene discussed is COL4A6; the disease is Alport syndrome.